Abstract
This review describes the non-exhaustive scenery of the synthesis of various biologically interesting pyrimidine annulated five-membered heterocyclic ring systems that have been appeared in the literature during the last two decades. During this period, different synthetic routes and various methodologies have been developed for the functionalization of pyrimidine ring towards the construction of five-membered heterocyclic rings. The aim of this review is to give an overview of the assorted methodologies that have been reported about the chemistry of construction of pyrimidines annulated nitrogen, oxygen and sulphur containing five-membered heterocycles.
Keywords: Pyrimidine annulated heterocycles, furopyrimidine, thienopyrimidine, pyrrolopyrimidine, imidazopyrimidine, indolopyrimidine, pyrazolopyrimidine, triazolopyrimidine.
Graphical Abstract
[http://dx.doi.org/10.1016/j.ejmech.2011.03.010] [PMID: 21450375]
(b) Lauria, A.; Patella, C.; Abbate, I.; Martorana, A.; Almerico, A.M. Lead optimization through VLAK protocol: New annelated pyrrolo-pyrimidine derivatives as antitumor agents. Eur. J. Med. Chem., 2012, 55, 375-383.
[http://dx.doi.org/10.1016/j.ejmech.2012.07.046] [PMID: 22892346 ]
(c) Roopan, S.M.; Khan, F.N.; Mandal, B.K. Fe nano particles mediated C-N bond-forming reaction: Regioselective synthesis of 3-[(2-chloroquinolin-3-yl)methyl]pyrimidin-4(3H)ones. Tetrahedron Lett., 2010, 51, 2309-2311.
[http://dx.doi.org/ 10.1016/j.tetlet.2010.02.128]
(d) Bharathi, A.; Roopan, S.M.; Vasavi, C.S.; Gayathri, G.A.; Gayathri, M. In silico molecular docking and in vitro antidiabetic studies of dihydropyrimido[4,5-a]acridin-2-amines. Biomed. Res. Inter., 2014, 971569, 1-9.
(e) Abou El Ella, D.A.; Ghorab, M.M.; Noaman, E.; Heiba, H.I.; Khalil, A.I. Molecular modeling study and synthesis of novel pyrrolo[2,3-d]pyrimidines and pyrrolotriazolopyrimidines of expected antitumor and radioprotective activities. Bioorg. Med. Chem., 2008, 16(5), 2391-2402.
[http://dx.doi.org/10.1016/j.bmc.2007.11.072] [PMID: 18086527]
(f) Gebauer, M.G.; McKinlay, C.; Gready, J.E. Synthesis of quaternised 2-aminopyrimido[4,5-d]pyrimidin-4(3H)-ones and their biological activity with dihydrofolate reductase. Eur. J. Med. Chem., 2003, 38(7-8), 719-728.
[http://dx.doi.org/10.1016/S0223-5234(03)00140-5] [PMID: 12932903]
[http://dx.doi.org/ 10.1016/j.tetlet.2016.09.047]
(b) Elattar, K.M.; Rabie, R.; Hammouda, M.M. Recent developments in the chemistry of bicyclic 6-6 systems: Chemistry of pyrido[1,2-c]pyrimidines. Synth. Commun., 2016, 46, 1477-1498.
[http://dx.doi.org/10.1080/00397911.2016.1211702 ]
(c) Jubeen, F.; Iqbal, S.Z.; Shafiq, N.; Khan, M.; Parveen, S.; Iqbal, M.; Nazir, A. Eco-friendly synthesis of pyrimidines and its derivatives: A review on broad spectrum bioactive moiety with huge therapeutic profile. Synth. Commun., 2018, 48, 601-625.
[http://dx.doi.org/ 10.1080/00397911.2017.1408840]
(d) Manvar, A.; Shah, A. Microwave-assisted chemistry of purines and xanthines. An overview. Tetrahedron, 2013, 69, 8105-8127.
[http://dx.doi.org/10.1016/j.tet.2013.06.034]
[http://dx.doi.org/10.1070/RC1985v054n03ABEH003026 ]
(b) Campaigne, E.; Ellis, R.L.; Bradford, M.; Ho, J. Synthesis of some ureidodihydrofurans and related pyrimidones as potential antimalarials. J. Med. Chem., 1969, 12(2), 339-342.
[http://dx.doi.org/10.1021/jm00302a041] [PMID: 5783618 ]
(c) Blume, F.; Arndt, F.; Ress, R. Ger Patent 3712782 1988.
(d) Bhuiyan, M.M.H.; Rahman, K.M.M.; Hossain, M.K.; Rahim, M.A.; Hossain, M.I. Fused pyrimidines. part II: Synthesis and antimicrobial activity of Some furo[3,2-e]imidazo[1,2-c]pyrimidines and furo[2,3-d]pyrimidines. Croat. Chem. Acta, 2005, 78, 633-636.
(e) Gangjee, A.; Zeng, Y.; McGuire, J.J.; Kisliuk, R.L. Synthesis of classical, four-carbon bridged 5-substituted furo[2,3-d]pyrimidine and 6-substituted pyrrolo[2,3-d]pyrimidine analogues as antifolates. J. Med. Chem., 2005, 48(16), 5329-5336.
[http://dx.doi.org/10.1021/jm058213s] [PMID: 16078850]
(f) Gangjee, A.; Zeng, Y.; Ihnat, M.; Warnke, L.A.; Green, D.W.; Kisliuk, R.L.; Lin, F.T. Novel 5-substituted, 2,4-diaminofuro[2,3-d]pyrimidines as multireceptor tyrosine kinase and dihydrofolate reductase inhibitors with antiangiogenic and antitumor activity. Bioorg. Med. Chem., 2005, 13(18), 5475-5491.
[http://dx.doi.org/10.1016/j.bmc.2005.04.087] [PMID: 16039863]
(g) Gangjee, A.; Zeng, Y.; McGuire, J.J.; Mehraein, F.; Kisliuk, R.L. Synthesis of classical, three-carbon-bridged 5-substituted furo[2,3-d] pyrimidine and 6-substituted pyrrolo[2,3-d]pyrimidine analogues as antifolates. J. Med. Chem., 2004, 47(27), 6893-6901.
[http://dx.doi.org/10.1021/jm040123k] [PMID: 15615538 ]
(h) Dave, C.G.; Shah, R.D. Annellation of triazole and tetrazole systems onto pyrrolo[2,3-d]pyrimidines: Synthesis of tetrazolo[1,5-c]-pyrrolo[3,2-e]-pyrimidines and Triazolo[1,5-c]pyrrolo-[3,2-e]pyrimidines as potential antibacterial agents. Molecules, 2002, 7, 554-565.
[http://dx.doi.org/10.3390/70700554 ]
(i)Janeba, Z.; Balzarini, J.; Andrei, G.; Snoeck, R.; De Clercq, E.; Robins, M.J. Synthesis and biological evaluation of acyclic 3-[(2-hydroxyethoxy)-methyl] analogues of antiviral furo- and pyrrolo[2,3-d]pyrimidine nucleosides. J. Med. Chem., 2005, 48, 4690-4696. (k) Robins, M.J.; Miranda, K.; Rajwanshi, V.K.; Peterson, M.A.; Andrei, G.; Snoeck, R.; De Clercq, E.; Balzarini, J. J. Synthesis and biological evaluation of 6-(alkyn-1-yl)furo[2,3-d]pyrimidin-2(3h)-one base and nucleoside derivatives. J. Med. Chem., 2006, 49, 391-398. l) McGuigan, C.; Balzarini, J. Aryl furanopyrimidines: The most potent and selective anti-VZV agents reported to date. Antiviral Res., 2006, 71, 149-153.
[http://dx.doi.org/10.1039/c1nj20121b]
[http://dx.doi.org/10.1055/s-2004-829133]
[http://dx.doi.org/10.1016/j.tetlet.2010.10.064 ]
(b) Zhu, Y.; Zhao, S.; Zhang, M.; Song, X.; Chang, J. Diastereoselective synthesis of spirobarbiturate-cyclopropanes through organobase-mediated spirocyclopropanation of barbiturate-based olefins with benzyl chlorides. Synthesis, 2019, 51, 899-906.
[http://dx.doi.org/10.1055/s-0037-1609637]
[http://dx.doi.org/10.1016/S0040-4020(01)00656-1 ]
(b) Majumdar, K.C.; Samanta, S.K. Synthesis of pyrimidine-annelated heterocycles: Regioselective heterocyclization of 5-(cyclohex-2-enyl)-1,3-dimethyl-6-hydroxyuracil. Monatsh. Chem., 2002, 133, 1187-1192.
[http://dx.doi.org/10.1007/s007060200088]
[http://dx.doi.org/10.1055/s-2006-948176]
[http://dx.doi.org/10.1016/j.tetlet.2012.01.106 ]
(b) Rao, M.S.; Esho, N.; Sergeant, C.; Dembinski, R. 5-Endo-dig electrophilic cyclization of α-alkynyl carbonyl compounds: Synthesis of novel bicyclic 5-iodo- and 5-bromofuranopyrimidine nucleosides. J. Org. Chem., 2003, 68(17), 6788-6790.
[http://dx.doi.org/10.1021/jo0345648] [PMID: 12919049]
[http://dx.doi.org/10.1016/j.tetlet.2019.03.017]
[http://dx.doi.org/10.1055/s-0034-1380321]
[http://dx.doi.org/10.1021/jo010224f] [PMID: 11442416]
(b) Prashad, M.; Har, D.; Chen, L.; Kim, H-Y.; Repic, O.; Blacklock, T.J. An efficient and large-scale enantioselective synthesis of PNP405: A purine nucleoside phosphorylase inhibitor. J. Org. Chem., 2002, 67(19), 6612-6617.
[http://dx.doi.org/10.1021/jo020256i] [PMID: 12227788 ]
(c) Kamath, V.P.; Juarez-Brambila, J.J.; Morris, C.B.; Winslow, C.D.; Morris, P.E. Development of a practical synthesis of a purine nucleoside phosphorylase inhibitor: BCX-4208. Org. Process Res. Dev., 2009, 13, 928-932.
[http://dx.doi.org/ 10.1021/op9001142]
(d) Semeraro, T.; Mugnaini, C.; Corelli, F. Preparation of a set of 4,5-dihydro-3H-pyrrolo[3,2-d]pyrimidin-4-ones as potential Hsp90 ligands. Tetrahedron Lett., 2008, 49, 5965-5967.
[http://dx.doi.org/ 10.1016/j.tetlet.2008.07.158]
(e) Oguro, Y.; Miyamoto, N.; Takagi, T.; Okada, K.; Awazu, Y.; Miki, H.; Hori, A.; Kamiyama, K.; Imamura, S. N-phenyl-N'-[4-(5H-pyrrolo[3,2-d]pyrimidin-4-yloxy)phenyl]ureas as novel inhibitors of VEGFR and FGFR kinases. Bioorg. Med. Chem., 2010, 18(20), 7150-7163.
[http://dx.doi.org/10.1016/j.bmc.2010.08.042] [PMID: 20833551 ]
(f) Gomtsyan, A.; Didomenico, S.; Lee, C.H.; Stewart, A.O.; Bhagwat, S.S.; Kowaluk, E.A.; Jarvis, M.F. Synthesis and biological evaluation of pteridine and pyrazolopyrimidine based adenosine kinase inhibitors. Bioorg. Med. Chem. Lett., 2004, 14(16), 4165-4168.
[http://dx.doi.org/10.1016/j.bmcl.2004.06.029] [PMID: 15261263]
(g) Ishikawa, T.; Seto, M.; Banno, H.; Kawakita, Y.; Oorui, M.; Taniguchi, T.; Ohta, Y.; Tamura, T.; Nakayama, A.; Miki, H.; Kamiguchi, H.; Tanaka, T.; Habuka, N.; Sogabe, S.; Yano, J.; Aertgeerts, K.; Kamiyama, K. Design and synthesis of novel human epidermal growth factor receptor 2 (HER2)/epidermal growth factor receptor (EGFR) dual inhibitors bearing a pyrrolo[3,2-d]pyrimidine scaffold. J. Med. Chem., 2011, 54(23), 8030-8050.
[http://dx.doi.org/10.1021/jm2008634] [PMID: 22003817 ]
(h) Xie, R.; Hu, Y.; Wan, H.; Hu, Y.; Chen, S.; Zhang, S.; Zhang, Y. An efficient synthesis of 4,6-substituted pyrrolo[3,2-d]pyrimidines by silver-catalyzed cyclization of acetylene amine. Tetrahedron Lett., 2016, 57, 2418-2421.
[http://dx.doi.org/10.1016/j.tetlet.2016.04.077]
[http://dx.doi.org/10.1016/j.tetlet.2018.06.039]
[http://dx.doi.org/ 10.1055/s-2005-861811]
(b) Majumdar, K.C.; Das, U.; Jana, N.K. Studies on pyrimidine-annelated heterocycles: Synthesis of pyrrolo[3,2-d]pyrimidines by amine oxide rearrangement. J. Org. Chem., 1998, 63, 3550-3553.
[http://dx.doi.org/10.1021/jo9718861]
[http://dx.doi.org/10.1016/j.tetlet.2011.05.141]
[http://dx.doi.org/10.1002/jhet.2520]
[http://dx.doi.org/10.1016/j.tetlet.2014.12.098 ]
(b) Mayasundari, A.; Fujii, N. Efficient formation of 4,6-disubstituted pyrrolo[2,3-d]pyrimidines: A novel route to TWS119, a glycogen synthase kinase-3β inhibitor. Tetrahedron Lett., 2010, 51, 3597-3598.
[http://dx.doi.org/10.1016/j.tetlet.2010.05.032 ]
(c) Prieur, V.; Rubio-Martinez, J.; Font-Bardia, M.; Guillaumet, G.; Pujol, M.D. Microwave-assisted synthesis of substituted pyrrolo[2,3-d] pyrimidines. Eur. J. Org. Chem., 2014, 1514-1524.
[http://dx.doi.org/10.1002/ejoc.201301496]
[http://dx.doi.org/10.1039/c2cy20117h]
[http://dx.doi.org/10.1055/s-0035-1561482]
[http://dx.doi.org/10.1039/c3mb70168a] [PMID: 23881296]
(b) Ghorab, M.M.; Ragab, F.A.; Heiba, H.I.; Youssef, H.A.; El-Gazzar, M.G. Synthesis of novel pyrrole and pyrrolo[2,3-d]pyrimidine derivatives bearing sulfonamide moiety for evaluation as anticancer and radiosensitizing agents. Bioorg. Med. Chem. Lett., 2010, 20(21), 6316-6320.
[http://dx.doi.org/10.1016/j.bmcl.2010.08.005] [PMID: 20850308 ]
(c) Clark, M.P.; George, K.M.; Bookland, R.G.; Chen, J.; Laughlin, S.K.; Thakur, K.D.; Lee, W.; Davis, J.R.; Cabrera, E.J.; Brugel, T.A.; VanRens, J.C.; Laufersweiler, M.J.; Maier, J.A.; Sabat, M.P.; Golebiowski, A.; Easwaran, V.; Webster, M.E.; De, B.; Zhang, G. Development of new pyrrolopyrimidine-based inhibitors of Janus kinase 3 (JAK3). Bioorg. Med. Chem. Lett., 2007, 17(5), 1250-1253.
[http://dx.doi.org/10.1016/j.bmcl.2006.12.018] [PMID: 17189692]
(d) Gangjee, A.; Zhao, Y.; Raghavan, S.; Ihnat, M.A.; Disch, B.C. Design, synthesis and evaluation of 2-amino-4-m-bromoanilino-6-arylmethyl-7H-pyrrolo[2,3-d]pyrimidines as tyrosine kinase inhibitors and antiangiogenic agents. Bioorg. Med. Chem., 2010, 18(14), 5261-5273.
[http://dx.doi.org/10.1016/j.bmc.2010.05.049] [PMID: 20558072 ]
(e) Wang, L.; Cherian, C.; Kugel Desmoulin, S.; Mitchell-Ryan, S.; Hou, Z.; Matherly, L.H.; Gangjee, A. Synthesis and biological activity of 6-substituted pyrrolo[2,3-d]pyrimidine thienoyl regioisomers as inhibitors of de novo purine biosynthesis with selectivity for cellular uptake by high affinity folate receptors and the proton-coupled folate transporter over the reduced folate carrier. J. Med. Chem., 2012, 55(4), 1758-1770.
[http://dx.doi.org/10.1021/jm201688n] [PMID: 22243528 ]
(f) Ding, S.; Wu, T.Y.H.; Brinker, A.; Peters, E.C.; Hur, W.; Gray, N.S.; Schultz, P.G. Synthetic small molecules that control stem cell fate. Proc. Natl. Acad. Sci. USA, 2003, 100(13), 7632-7637.
[http://dx.doi.org/10.1073/pnas.0732087100] [PMID: 12794184 ]
(g) Wang, Y.; Mitchell-Ryan, S.; Raghavan, S.; George, C.; Orr, S.; Hou, Z.; Matherly, L.H.; Gangjee, A. Novel 5-substituted pyrrolo[2,3-d]pyrimidines as dual inhibitors of glycinamide ribonucleotide formyltransferase and 5-amino-imidazole-4-carboxamide ribonucleotide formyltransferase and as potential antitumor agents. J. Med. Chem., 2015, 58(3), 1479-1493.
[http://dx.doi.org/10.1021/jm501787c] [PMID: 25602637]
[http://dx.doi.org/10.1016/j.bmcl.2015.12.047] [PMID: 26739778]
[http://dx.doi.org/10.1021/jo030248h] [PMID: 14682686]
[http://dx.doi.org/10.1055/s-0036-1588757]
[http://dx.doi.org/10.1055/s-0035-1561277]
[http://dx.doi.org/10.1016/j.tetlet.2014.07.119]
[http://dx.doi.org/10.1055/s-0031-1289526]
[http://dx.doi.org/10.1016/j.scr.2017.03.014] [PMID: 28368243]
(b) Fares, I.; Chagraoui, J.; Gareau, Y.; Gingras, S.; Ruel, R.; Mayotte, N.; Csaszar, E.; Knapp, D.J.H.F.; Miller, P.; Ngom, M.; Imren, S.; Roy, D-C.; Watts, K.L.; Kiem, H-P.; Herrington, R.; Iscove, N.N.; Humphries, R.K.; Eaves, C.J.; Cohen, S.; Marinier, A.; Zandstra, P.W.; Sauvageau, G. Cord blood expansion. Pyrimidoindole derivatives are agonists of human hematopoietic stem cell self-renewal. Science, 2014, 345(6203), 1509-1512.
[http://dx.doi.org/10.1126/science.1256337] [PMID: 25237102]
[http://dx.doi.org/10.1002/ejoc.201200276 ]
(b) Ren, Y-w.; Wang, X.; Wang, W.; Li, B.; Shi, Z-j.; Zhang, W. Photochemical and thermal cyclizations of 4-(2-azidophenyl)-3,4-dihydropyri-midin-2-ones for the synthesis of 4-methylenepyrimidino[5,4-b]indol-2-ones. Tetrahedron Lett., 2011, 52, 192-195.
[http://dx.doi.org/10.1016/j.tetlet.2010.10.176]
[http://dx.doi.org/10.1016/j.tetlet.2011.06.021]
[http://dx.doi.org/10.1016/j.tetlet.2016.07.052]
[http://dx.doi.org/10.1021/acs.orglett.5b03231] [PMID: 26710082]
[http://dx.doi.org/10.1055/s-0032-1316857]
[http://dx.doi.org/10.5012/jkcs.2011.55.4.719]
[http://dx.doi.org/10.1002/hc.20046]
[http://dx.doi.org/10.1016/j.tetlet.2006.02.031]
[http://dx.doi.org/10.1016/j.tetlet.2007.07.041 ]
(b) Quiroga, J.; Portilla, J.; Abonıa, R.; Insuasty, B.; Nogueras, M.; Cobo, J. Regioselective synthesis of novel substituted pyrazolo[1,5-a] pyrimidines under solvent-free conditions. Tetrahedron Lett., 2008, 49, 6254-6256.
[http://dx.doi.org/10.1016/j.tetlet.2008.08.044]
[http://dx.doi.org/10.3987/COM-07-11196]
[http://dx.doi.org/10.1055/s-0033-1339977]
[http://dx.doi.org/10.1055/s-0031-1289733 ]
(b) Stepaniuk, O.O.; Matviienko, V.O.; Kondratov, I.S.; Vitruk, I.V.; Tolmachev, A.O. Synthesis of new pyrazolo[1,5-a]pyrimidines by reaction of β,γ-unsaturated γ-alkoxy-α-keto esters with n-unsubstituted 5-aminopyra-zoles. Synthesis, 2013, 45, 925-930.
[http://dx.doi.org/10.1055/s-0032-1318329]
[http://dx.doi.org/10.1016/j.tetlet.2013.03.015]
[http://dx.doi.org/10.1002/ejoc.201701024 ]
(b) Jismy, B.; Allouchi, H.; Guillaumet, G.; Akssira, M.; Abarbri, M. An Efficient synthesis of new 7-trifluoromethyl-2,5-disubstituted pyrazolo[1,5-a]pyrimidines. Synthesis, 2018, 50, 1675-1686.
[http://dx.doi.org/10.1055/s-0036-1591752]
[http://dx.doi.org/10.1002/jhet.2496]
[http://dx.doi.org/10.1055/s-0033-1338514]
[http://dx.doi.org/10.1039/p19800000481]
[http://dx.doi.org/ 10.1016/j.tetlet.2007.11.054]
(b) Quiroga, J.; Mejia, D.; Insuasty, B.; Abonia, R.; Nogueras, M.; Sanchez, A.; Cobo, J. Synthesis of 6-(2-hydroxybenzoyl)pyrazolo[1,5a]pyrimidines by reaction of -5-amino-1h-pyrazoles and 3-formylchromone. J. Heterocycl. Chem., 2002, 39, 51-54.
[http://dx.doi.org/10.1002/jhet.5570390106]
[http://dx.doi.org/10.1016/j.tetlet.2014.05.021]
[http://dx.doi.org/10.1016/j.tetlet.2014.04.011]
[http://dx.doi.org/10.1021/jm100350r] [PMID: 20560595 ]
(b) Petrov, A.A.; Kasatochkin, A.N.; Emelina, E.E. Study of regioselectivity of reactions between 3(5)-aminopyrazoles and 2-acetylcycloalkanones. Russ. J. Org. Chem., 2012, 48, 1111-1120.
[http://dx.doi.org/10.1134/S1070428012080131]
[http://dx.doi.org/ 10.3987/COM-07-11240]
(b) Zimmerman, J.R.; Myers, B.J.; Bouhall, S.; McCarthy, A.; Johntony, O.; Manpadi, M. A two-step, single pot procedure for the synthesis of substituted dihydropyrazolo-pyrimidines. Tetrahedron Lett., 2014, 55, 936-940.
[http://dx.doi.org/10.1016/j.tetlet.2013.12.057]
[http://dx.doi.org/10.1021/co300063x] [PMID: 22775440]
(b) Ryabukhina, S.V.; Granat, D.S.; Plaskon, A.S.; Shivanyuk, A.; Lukin, O. Synthesis of pyrazolo[3,4-d]-4,5-dihydropyrimidin-6-ones. Tetrahedron Lett., 2014, 55, 1846-1847.
[http://dx.doi.org/10.1016/j.tetlet.2014.01.131]
[http://dx.doi.org/10.1016/j.tetlet.2008.10.065]
[http://dx.doi.org/10.1016/j.tetlet.2007.04.043]
[http://dx.doi.org/10.1055/s-0037-1612081]
[http://dx.doi.org/10.1016/j.tet.2013.07.055]
[http://dx.doi.org/10.1055/s-0033-1338862]
[http://dx.doi.org/10.1080/00397911.2014.996296]
[http://dx.doi.org/10.1046/j.1468-1331.2002.00421.x] [PMID: 12099922 ]
(b) Cui, P.; Macdonald, T.L.; Chen, M.; Nadler, J.L. Synthesis and biological evaluation of lisofylline (LSF) analogs as a potential treatment for Type 1 diabetes. Bioorg. Med. Chem. Lett., 2006, 16(13), 3401-3405.
[http://dx.doi.org/10.1016/j.bmcl.2006.04.036] [PMID: 16650991 ]
(c) Stine, R.J.; Marcus, R.H.; Parvin, C.A. Aminophylline loading in asthmatic patients: A protocol trial. Ann. Emerg. Med., 1989, 18(6), 640-646.
[http://dx.doi.org/10.1016/S0196-0644(89)80518-9] [PMID: 2658694]
(d) Song, B.; Xiao, T.; Qi, X.; Li, L-N.; Qin, K.; Nian, S.; Hu, G-X.; Yu, Y.; Liang, G.; Ye, F. Design and synthesis of 8-substituted benzamido-phenylxanthine derivatives as MAO-B inhibitors. Bioorg. Med. Chem. Lett., 2012, 22(4), 1739-1742.
[http://dx.doi.org/10.1016/j.bmcl.2011.12.094] [PMID: 22257893]
(e) Roy, A.C.; Lunn, F.A.; Bearne, S.L. Inhibition of CTP synthase from Escherichia coli by xanthines and uric acids. Bioorg. Med. Chem. Lett., 2010, 20(1), 141-144.
[http://dx.doi.org/10.1016/j.bmcl.2009.11.017] [PMID: 20004571 ]
(f) Szentmiklósi, A.J.; Cseppentō, A.; Gesztelyi, R.; Zsuga, J.; Körtvély, A.; Harmati, G.; Nánási, P.P. Xanthine derivatives in the heart: blessed or cursed? Curr. Med. Chem., 2011, 18(24), 3695-3706.
[http://dx.doi.org/10.2174/092986711796642391] [PMID: 21774759 ]
(g) Nehlig, A.; Daval, J-L.; Debry, G. Caffeine and the central nervous system: mechanisms of action, biochemical, metabolic and psychostimulant effects. Brain Res. Brain Res. Rev., 1992, 17(2), 139-170.
[http://dx.doi.org/10.1016/0165-0173(92)90012-B] [PMID: 1356551]
(h) Schultze-Werninghaus, G.; Meier-Sydow, J. The clinical and pharmacological history of theophylline: first report on the bronchospasmolytic action in man by S. R. Hirsch in Frankfurt (Main) 1922. Clin. Allergy, 1982, 12(2), 211-215.
[http://dx.doi.org/10.1111/j.1365-2222.1982.tb01641.x] [PMID: 7042115]
(i)Watanabe, Y.; Murata, T.; Shimizu, K.; Morita, H.; Inui, M.; Tagawa, T. Phosphodiesterase 4 regulates the migration of B16-F10 melanoma cells. Exp. Ther. Med., 2012, 4(2), 205-210.
[http://dx.doi.org/10.3892/etm.2012.587] [PMID: 22970026 ]
(j)Tesarik, J.; Mendoza, C.; Carreras, A. Effects of phosphodiesterase inhibitors caffeine and pentoxifylline on spontaneous and stimulus-induced acrosome reactions in human sperm. Fertil. Steril., 1992, 58(6), 1185-1190.
[http://dx.doi.org/10.1016/S0015-0282(16)55567-8] [PMID: 1333994]
[http://dx.doi.org/10.1081/SCC-120023986]
[http://dx.doi.org/10.1016/j.bmcl.2004.11.044] [PMID: 15664822 ]
(b) Nieto, M.I.; Balo, M.C.; Brea, J.; Caamaño, O.; Cadavid, M.I.; Fernández, F.; Mera, X.G.; López, C.; Rodríguez-Borges, J.E. Synthesis of novel 1-alkyl-8-substituted-3-(3-methoxypropyl) xanthines as putative A(2B) receptor antagonists. Bioorg. Med. Chem., 2009, 17(9), 3426-3432.
[http://dx.doi.org/10.1016/j.bmc.2009.03.029] [PMID: 19346133]
[http://dx.doi.org/10.1016/j.tet.2012.03.050]
[http://dx.doi.org/10.1016/j.tetlet.2012.04.135]
[http://dx.doi.org/10.1016/j.tetlet.2008.05.071]
[http://dx.doi.org/10.1016/S0960-894X(02)00296-2] [PMID: 12113821]
[http://dx.doi.org/10.1055/s-0036-1588821]
[http://dx.doi.org/ 10.1055/s-0034-1379237]
(b) Liu, B.; Gong, Y.; Lu, S.; Li, D.; Fan, H. Synthesis of fused purine heterocycles via a one-pot cascade reaction of a trisubstituted pyrimidine. Synlett, 2018, 29, 1796-1800.
[http://dx.doi.org/10.1055/s-0036-1591585]
[http://dx.doi.org/10.1016/j.tet.2013.09.063]
[http://dx.doi.org/10.3987/COM-17-13694]
[http://dx.doi.org/10.1021/jm00397a032] [PMID: 2892936]
(b) Hirota, T.; Sasaki, K.; Tashima, Y.; Nakayama, T. Polycyclic N-hetero compounds. XXXIV. Syntheses and evaluation of antidepressive activity of benzofuro-[2,3-e]imidazo[1,2-c]pyrimidines and their precursors. J. Heterocycl. Chem., 1991, 28, 263-267.
[http://dx.doi.org/ 10.1002/jhet.5570280210]
(c) Camp, D.; Li, Y.; McCluskey, A.; Moni, R.W.; Quinn, R.J. Diimidazo[1,2-c:4′,5′-e]pyrimidines: N6-N1 conformationally restricted adenosines. Bioorg. Med. Chem. Lett., 1998, 8(6), 695-698.
[http://dx.doi.org/10.1016/S0960-894X(98)00101-2] [PMID: 9871585]
(d) Peet, N.P.; Lentz, N.L.; Sunder, S.; Dudley, M.W.; Ogden, A.M.L. Conformationally restrained, chiral (phenylisopropyl)amino-substituted pyrazolo[3,4-d]pyrimidines and purines with selectivity for adenosine A1 and A2 receptors. J. Med. Chem., 1992, 35(17), 3263-3269.
[http://dx.doi.org/10.1021/jm00095a024] [PMID: 1507211]
(e) Chhabria, M.T.; Jani, M.H. Design, synthesis and antimycobacterial activity of some novel imidazo[1,2-c]pyrimidines. Eur. J. Med. Chem., 2009, 44(10), 3837-3844.
[http://dx.doi.org/10.1016/j.ejmech.2009.04.002] [PMID: 19423196]
[http://dx.doi.org/10.1055/s-0033-1339350]
[http://dx.doi.org/10.1080/00397911.2012.707738]
[http://dx.doi.org/10.1055/s-0036-1588425]
[http://dx.doi.org/ 10.1016/j.tet.2017.07.025]
(b) Liu, J.; Lei, M.; Hu, L. Thiamine hydrochloride (VB1): an efficient promoter for the one-pot synthesis of benzo[4,5]imidazo[1,2-a]pyrimidine and [1,2,4]triazolo[1,5-a]pyrimidine derivatives in water medium. Green Chem., 2012, 14, 840-846.
[http://dx.doi.org/ 10.1039/c2gc16499j]
(c) Hemmati, B.; Javanshir, S.; Dolatkhah, Z. Hybrid magnetic Irish moss/Fe3O4 as a nano-biocatalyst for synthesis of imidazopyrimidine derivatives. RSC Advances, 2016, 6, 50431-50436.
[http://dx.doi.org/10.1039/C6RA08504K ]
(d) Kalita, S.J.; Deka, D.C.; Mecadon, H. Organocatalytic domino Knöevenagel-Michael reaction in water for the regioselective synthesis of benzo[4,5]imidazo[1,2-a]pyrimidines and pyrido[2,3-d]pyrimidin-2-amines. RSC Advances, 2016, 6, 91320-91324.
[http://dx.doi.org/10.1039/C6RA21376F]
[http://dx.doi.org/10.1016/j.tetlet.2018.01.008]
[http://dx.doi.org/10.1002/ejoc.201000808]
[http://dx.doi.org/10.1016/j.tetlet.2018.05.005]
(b) Ho, S.L.; Dao, P.D.Q.; Cho, C.S. Microwave-assisted synthesis of benzo[4,5]imidazo[1,2-a]pyrimidines from β-bromo-α,β-unsaturated aldehydes and 2-aminobenzi-midazoles. Synlett, 2017, 28, 1811-1815.
[http://dx.doi.org/10.1055/s-0036-1588834]
[http://dx.doi.org/10.1006/phrs.2001.0864] [PMID: 11592868 ]
(b) Liu, M.; Sun, Q.; Wang, Q.; Wang, X.; Lin, P.; Yang, M.; Yan, Y. Effect of trapidil in myocardial ischemia-reperfusion injury in rabbit. Indian J. Pharmacol., 2014, 46(2), 207-210.
[http://dx.doi.org/10.4103/0253-7613.129320] [PMID: 24741195]
(c) Gomha, S.M.; Mohamed, A.M.G.; Zaki, Y.H.; Ewies, M.M.; Elroby, S.A. Structural elucidation and antimicrobial evaluation of novel [1,2,4]Triazolo[4,3-a]pyrimidines and Pyrido[2,3-d][1,2,4]triazolo[4,3-a]pyrimidinones. J. Heterocycl. Chem., 2018, 55, 1147-1156.
[http://dx.doi.org/ 10.1002/jhet.3146]
(d) Edrees, M.M.; Farghaly, T.A. Synthesis and antitumor activity of benzo [6 ″, 7 ″] cyclohepta [1 ″, 2 ″: 4′, 5′] pyrido [2′, 3′-d][1, 2, 4] triazolo [4, 3-a] pyrimidin-5-ones. Arab. J. Chem., 2017, 10, S1613.
[http://dx.doi.org/ 10.1016/j.arabjc.2013.06.002]
(e) Kumar Biswas, B.; Malpani, Y.R.; Ha, N.; Kwon, D.H.; Soo Shin, J.; Kim, H.S.; Kim, C.; Bong Han, S.; Lee, C.K.; Jung, Y.S. Enterovirus inhibitory activity of C-8-tert-butyl substituted 4-aryl-6,7,8,9-tetrahydro-benzo[4,5]thieno[3,2-e][1,2,4]triazolo[4,3-a]pyrimidin-5(4H)-ones. Bioorg. Med. Chem. Lett., 2017, 27(15), 3582-3585.
[http://dx.doi.org/10.1016/j.bmcl.2017.05.030] [PMID: 28587824]
(f) Pan, F.J.; Wang, S.B.; Liu, D.C.; Gong, G.H.; Quan, Z.S. Synthesis of 4-phenylthieno[2,3-e][1,2,4]triazolo[4,3-a]pyrimidine-5(4h)-one derivatives and evaluation of their anti-inflammatory activity. Lett. Drug Des. Discov., 2016, 13, 141-148.
[http://dx.doi.org/10.2174/1570180812666150630184439]
(b) Tang, C.; Wang, C.; Li, Z.; Wang, Q. Synthesis of 8-Bromo-7-chloro[1,2,4]triazolo[4,3-c]pyrimidines, their ring rearrangement to [1,5-c] analogues, and further diversification. Synthesis, 2014, 46, 2734-2746.
[http://dx.doi.org/10.1055/s-0034-1378453]
[http://dx.doi.org/10.1055/s-0034-1380677]
[http://dx.doi.org/10.1016/j.tetlet.2013.11.090]
[http://dx.doi.org/10.1016/j.tetlet.2014.12.135]
[http://dx.doi.org/10.1016/j.tetlet.2017.02.035]
[http://dx.doi.org/10.1080/00397911.2015.1083579]
[http://dx.doi.org/10.1080/00397911.2017.1332223]
[http://dx.doi.org/10.1134/S1070428009030117 ]
(b) Andrade, V.P.; Mittersteiner, M.; Bonacorso, H.G.; Frizzo, C.P.; Martins, M.A.P.; Zanatta, N. Regioselective Synthesis of 5-(Trifluoromethyl)[1, 2,4]triazolo[1,5-a]pyrimidi-nes from β-Enamino Diketones. Synthesis, 2019, 51, 2311-2317.
[http://dx.doi.org/ 10.1055/s-0037-1611765]
(c) Frizzo, C.P.; Scapin, E.; Marzari, M.R.B.; München, T.S.; Zanatta, N.; Bonacorso, H.G.; Buriol, L.; Martins, M.A.P. Ultrasound irradiation promotes the synthesis of new 1,2,4-triazolo[1,5-a]pyrimidine. Ultrason. Sonochem., 2014, 21(3), 958-962.
[http://dx.doi.org/10.1016/j.ultsonch.2013.12.007] [PMID: 24394386 ]
(d) Chernyshev, V.M.; Astakhov, A.V.; Starikova, Z.A. Reaction of 1-substituted 3,5-diamino-1,2,4-triazoles with β-keto esters: Synthesis and new rearrangement of mesoionic 3-amino-2H-[1,2,4]triazolo-[4,3-a]pyrimidin-5-ones. Tetrahedron, 2010, 66, 3301-3313.
[http://dx.doi.org/10.1016/j.tet.2010.03.009]
[http://dx.doi.org/10.1055/s-0037-1610191]
[http://dx.doi.org/10.1002/jhet.3222]
[http://dx.doi.org/10.1016/S0065-2725(08)60831-4 ]
(b) Fischer, G. Recent progress in 1,2,4-triazolo[1,5-a]pyrimidine chemistry. Adv. Heterocycl. Chem., 2008, 95, 143-219.
[http://dx.doi.org/10.1016/S0065-2725(07)95003-5 ]
(c) Ohnishi, H.; Yamaguchi, K.; Shimada, S.; Suzuki, Y.; Kumagai, A. A new approach to the treatment of atherosclerosis and trapidil as an antagonist to platelet-derived growth factor. Life Sci., 1981, 28(14), 1641-1646.
[http://dx.doi.org/10.1016/0024-3205(81)90320-9] [PMID: 6264257 ]
(d) Novinson, T.; Springer, R.H. OíBrien, D.E.; Scholten, M.B.; Miller, J.P.; Robins, R.K. 2-(Alkylthio)-1,2,4-triazolo[1,5-a]pyrimidines as adenosine 3′,5′-monophosphate phosphodiesterase inhibitors with potential as new cardiovascular agents. J. Med. Chem., 1982, 25, 420-426.
[http://dx.doi.org/10.1021/jm00346a017] [PMID: 6279846]
(e) Gujjar, R.; Marwaha, A.; El Mazouni, F.; White, J.; White, K.L.; Creason, S.; Shackleford, D.M.; Baldwin, J.; Charman, W.N.; Buckner, F.S.; Charman, S.; Rathod, P.K.; Phillips, M.A. Identification of a metabolically stable triazolopyrimidine-based dihydroorotate dehydrogenase inhibitor with antimalarial activity in mice. J. Med. Chem., 2009, 52(7), 1864-1872.
[http://dx.doi.org/10.1021/jm801343r] [PMID: 19296651]
(f) Chen, Q.; Zhu, X.L.; Jiang, L.L.; Liu, Z.M.; Yang, G.F. Synthesis, antifungal activity and CoMFA analysis of novel 1,2,4-triazolo[1,5-a]pyrimidine derivatives. Eur. J. Med. Chem., 2008, 43(3), 595-603.
[http://dx.doi.org/10.1016/j.ejmech.2007.04.021] [PMID: 17618711 ]
(g) Yu, W.; Goddard, C.; Clearfield, E.; Mills, C.; Xiao, T.; Guo, H.; Morrey, J.D.; Motter, N.E.; Zhao, K.; Block, T.M.; Cuconati, A.; Xu, X. Design, synthesis, and biological evaluation of triazolo-pyrimidine derivatives as novel inhibitors of hepatitis B virus surface antigen (HBsAg) secretion. J. Med. Chem., 2011, 54(16), 5660-5670.
[http://dx.doi.org/10.1021/jm200696v] [PMID: 21786803 ]
(h) El-Gendy, M.M.A.; Shaaban, M.; Shaaban, K.A.; El-Bondkly, A.M.; Laatsch, H. Essramycin: A first triazolopyrimidine antibiotic isolated from nature. J. Antibiot. (Tokyo), 2008, 61(3), 149-157.
[http://dx.doi.org/10.1038/ja.2008.124] [PMID: 18503193 ]
(i)Allen, J.G.; Bourbeau, M.P.; Wohlhieter, G.E.; Bartberger, M.D.; Michelsen, K.; Hungate, R.; Gadwood, R.C.; Gaston, R.D.; Evans, B.; Mann, L.W.; Matison, M.E.; Schneider, S.; Huang, X.; Yu, D.; Andrews, P.S.; Reichelt, A.; Long, A.M.; Yakowec, P.; Yang, E.Y.; Lee, T.A.; Oliner, J.D. Discovery and optimization of chromenotriazolopyrimidines as potent inhibitors of the mouse double minute 2-tumor protein 53 protein-protein interaction. J. Med. Chem., 2009, 52(22), 7044-7053.
[http://dx.doi.org/10.1021/jm900681h] [PMID: 19856920 ]
(j)Tang, W.; Shi, D.Q. Synthesis and herbicidal activity of O,O-dialkyl N-[2-(5,7-dimethyl-[1,2,4]triazolo[1,5-a]pyrimidin-2-yloxy)benzoxyl]-1-amino-1-substitutedbe-nzyl phosphonates. J. Heterocycl. Chem., 2010, 47, 162-166.
(k)Chen, Q.; Liu, Z.M.; Chen, C.N.; Jiang, L.L.; Yang, G.F. Synthesis and fungicidal activities of new 1,2,4-triazolo[1,5-a]pyrimidines. Chem. Biodivers., 2009, 6(8), 1254-1265.
[http://dx.doi.org/10.1002/cbdv.200800168] [PMID: 19697344 ]
(l)El-Koussi, N.A.; Omar, F.A.; Abdel-Aziz, S.A.; Radwan, M.F. Synthesis and antibacterial screening of some 2, 5, 7-triaryl-1, 2, 4-triazolo. Pyrimidines. Bull. Pharm. Sci., 2004, 27, 141-154.
(m)Lakomska, I.; Wojtczak, A.; Sitkowski, J.; Kozerski, L.; Szlyk, E. Platinum(IV) complexes with purine analogs. Studies of molecular structure and antiproliferative activity in vitro. Polyhedron, 2008, 27, 2765-2770.
[http://dx.doi.org/10.1016/j.poly.2008.05.032 ]
(n)Lakomska, I. Molecular structure and antitumor activity of platinum(II) complexes containing purine analogs. Inorg. Chim. Acta, 2009, 362, 669-681. http://
[http://dx.doi.org/10.1016/j.ica.2008.02.030]
[http://dx.doi.org/10.1080/00397911.2011.566460]
[http://dx.doi.org/10.1080/00397911.2019.1566476]
[http://dx.doi.org/10.1016/j.tetlet.2007.07.039]
[http://dx.doi.org/10.1042/BJ20121871] [PMID: 23418854]
(b) Horiuchi, T.; Takeda, Y.; Haginoya, N.; Miyazaki, M.; Nagata, M.; Kitagawa, M.; Akahane, K.; Uoto, K. Discovery of novel Thieno[2,3-d]pyrimidin-4-yl hydrazone-based cyclin-dependent kinase 4 inhibitors: synthesis, biological evaluation and structure-activity relationships. Chem. Pharm. Bull. (Tokyo), 2011, 59(8), 991-1002.
[http://dx.doi.org/10.1248/cpb.59.991] [PMID: 21804244]
(c) Horiuchi, T.; Nagata, M.; Kitagawa, M.; Akahane, K.; Uoto, K. Discovery of novel thieno[2,3-d]pyrimidin-4-yl hydrazone-based inhibitors of cyclin D1-CDK4: Synthesis, biological evaluation and structure-activity relationships. Part 2. Bioorg. Med. Chem., 2009, 17(23), 7850-7860.
[http://dx.doi.org/10.1016/j.bmc.2009.10.039] [PMID: 19889545 ]
(d) McClellan, W.J.; Dai, Y.; Abad-Zapatero, C.; Albert, D.H.; Bouska, J.J.; Glaser, K.B.; Magoc, T.J.; Marcotte, P.A.; Osterling, D.J.; Stewart, K.D.; Davidsen, S.K.; Michaelides, M.R. Discovery of potent and selective thienopyrimidine inhibitors of Aurora kinases. Bioorg. Med. Chem. Lett., 2011, 21(18), 5620-5624.
[http://dx.doi.org/10.1016/j.bmcl.2011.06.041] [PMID: 21778056 ]
(e) Gangjee, A.; Li, W.; Kisliuk, R.L.; Cody, V.; Pace, J.; Piraino, J.; Makin, J. Design, synthesis, and X-ray crystal structure of classical and nonclassical 2-amino-4-oxo-5-substituted-6-ethylthieno[2,3-d]pyrimidines as dual thymi-dylate synthase and dihydrofolate reductase inhibitors and as potential antitumor agents. J. Med. Chem., 2009, 52(15), 4892-4902.
[http://dx.doi.org/10.1021/jm900490a] [PMID: 19719239 ]
(f) Gangjee, A.; Qiu, Y.; Li, W.; Kisliuk, R.L. Potent dual thymidylate synthase and dihydrofolate reductase inhibitors: classical and nonclassical 2-amino-4-oxo-5-arylthio-substituted-6-methylthieno[2,3-d] pyrimidine antifolates. J. Med. Chem., 2008, 51(18), 5789-5797.
[http://dx.doi.org/10.1021/jm8006933] [PMID: 18800768]
(g) Gangjee, A.; Qiu, Y.; Kisliuk, R.L. Synthesis of classical and nonclassical 2-amino-4-oxo-6-benzylthieno-[2,3-d]pyrimidines as potential thymidylate synthase inhibitors. J. Heterocycl. Chem., 2004, 41, 941-946.
[http://dx.doi.org/10.1002/jhet.5570410613]
[http://dx.doi.org/10.2174/157017807780414127 ]
(b) Majumdar, K.C.; Pal, N.; Chattopadhyay, S.K. An efficient route to thieno[2,3-d]pyrimidine derivatives by tandem [2, 3] and Sigmatropic Rearrangement. Lett. Org. Chem., 2006, 3, 709-711. [3, 3].
[http://dx.doi.org/10.2174/157017806778700033]
[http://dx.doi.org/10.3987/COM-12-12463]
[http://dx.doi.org/10.3987/COM-15-13236]
[http://dx.doi.org/10.1016/j.tetlet.2015.05.104]
[http://dx.doi.org/10.1016/j.tetlet.2016.04.088]
[http://dx.doi.org/10.1002/jhet.2972]
[http://dx.doi.org/10.1016/j.tetlet.2015.03.082]
[http://dx.doi.org/10.1016/j.tetlet.2016.01.006]
[http://dx.doi.org/ 10.1016/j.tetlet.2014.08.051]
(b) Roy, B.; Hazra, S.; Mondal, B.; Majumdar, K.C. Cu(OTf)2-catalyzed dehydrogenative C-H activation under atmospheric oxygen: An expedient approach to pyrrolo[3,2-d] pyrimidine derivatives. Eur. J. Org. Chem., 2013, 4570-4577.
[http://dx.doi.org/10.1002/ejoc.201300275]
[http://dx.doi.org/10.1055/s-0037-1609364]
[http://dx.doi.org/10.1016/j.tet.2017.10.024 ]
(b) Liu, X.; Song, X.; Liu, Y.; Xie, M.; Yu, W.; Yan, S.; Lin, J.; Jin, Y. Novel 5H-[1,2,4]oxadiazolo[4,5-a]pyri-midin-5-one derivatives as antibacterial and anticancer agents: Synthesis and biological evaluation. Tetrahedron Lett., 2018, 59, 3767-3772.
[http://dx.doi.org/10.1016/j.tetlet.2018.09.011]
[http://dx.doi.org/10.1016/j.ejmech.2010.12.014] [PMID: 21255878]
(b) Zhi, H.; Chen, L-M.; Zhang, L-L.; Liu, S-J.; Wan, D.C.C.; Lin, H-Q.; Hu, C. Design, synthesis, and biological evaluation of 5H-thiazolo[3,2-a]pyrimidine derivatives as a new type of acetylcholinesterase inhibitors. ARKIVOC, 2008, 13, 266-277.
(c) Quan, Z-J.; Zhang, Z.; Wang, J-K.; Wang, X-C.; Liu, Y-J.; Ji, P-Y. Efficient synthesis of 5H-thiazolo[3,2-a]pyrimidines from reactions of 3,4-dihydropyrimidine-thiones with α-bromoacetone in aqueous media. Heteroatom Chem., 2008, 2, 149-153.
[http://dx.doi.org/10.1002/hc.20386]
[http://dx.doi.org/10.1016/j.tetlet.2011.05.067]
[http://dx.doi.org/10.3987/COM-13-12797]
[http://dx.doi.org/10.1016/S0040-4020(03)00854-8]
[http://dx.doi.org/10.1039/c2ra20254a ]
(b) Shelke, A.V.; Bhong, B.Y.; Karade, N.N. New synthesis of 3,5-disubstituted-5H-thiazolo[3,2-a]pyrimidine via ring annulation of 3,4-dihydropyrimidin-2(1H)-thione using alkynyl(aryl)iodonium salts. Tetrahedron Lett., 2013, 54, 600-603.
[http://dx.doi.org/10.1016/j.tetlet.2012.11.098]
[http://dx.doi.org/ 10.3987/COM-08-11365]
(b) Studzinska, R.; Wroblewski, M.; Karczmarska-Wodzka, A.; Kołodziejska, R. A facile synthesis of the novel thiazolo[3,2-a]pyrimidine derivatives. Tetrahedron Lett., 2014, 55, 1384-1386.
[http://dx.doi.org/10.1016/j.tetlet.2014.01.033]
[http://dx.doi.org/10.1055/s-0035-1562459]
[http://dx.doi.org/10.1002/jhet.3174 ]
(b) Elmaaty, T.A.; El-Taweel, F.; Abdeldayem, S.; Elfarh, A.A. Synthesis of some new thiazolo[3,2-a]pyrimidine derivatives and their applications as disperse dyes. J. Heterocycl. Chem., 2019, 56, 922-929.
[http://dx.doi.org/10.1002/jhet.3470]
[http://dx.doi.org/10.1055/s-0034-1378332 ]
(b) Dong, H.; Zhao, Y. Highly regioselective synthesis of 7-oxo-7h-[1,3,4]thiadiazolo[3,2-a]pyrimidine-5-carboxylate derivatives under mild conditions. Tetrahedron Lett., 2019, 60, 1399-1403.
[http://dx.doi.org/10.1016/j.tetlet.2019.04.005]
[http://dx.doi.org/10.1016/j.tetlet.2014.06.073]
[http://dx.doi.org/10.1016/j.tetlet.2018.06.068]
[http://dx.doi.org/10.1055/s-0037-1609302]
[http://dx.doi.org/10.1002/jhet.2521]
[http://dx.doi.org/10.1016/j.tetlet.2017.07.071]
[http://dx.doi.org/10.1016/j.tetlet.2012.12.077]
[http://dx.doi.org/10.1016/j.tetlet.2015.01.146]
[http://dx.doi.org/10.1016/j.tetlet.2017.01.030]
[http://dx.doi.org/10.1080/00397911.2018.1514053]
[http://dx.doi.org/10.1055/s-0035-1560496]
[http://dx.doi.org/10.1080/00397911.2014.943344]
[http://dx.doi.org/10.1016/j.tetlet.2009.07.113]
[http://dx.doi.org/10.1016/j.bmcl.2016.09.062] [PMID: 27720296]
[http://dx.doi.org/10.1002/jhet.2006]
[http://dx.doi.org/ 10.1007/s10593-015-1725-2]
(b) Gorbunov, E.B.; Rusinov, G.L.; Ulomsky, E.N.; Rusinov, V.L.; Charushin, V.N.; Chupakhin, O.N. C–H functionalization of triazolo[a]-annulated 8-azapurines. Tetrahedron Lett., 2016, 57, 2303-2305.
[http://dx.doi.org/10.1016/j.tetlet.2016.04.052]
[http://dx.doi.org/10.1016/j.tetlet.2013.10.062]
[http://dx.doi.org/10.1016/j.tetlet.2013.06.136]
[http://dx.doi.org/10.1002/jhet.2346]
[http://dx.doi.org/10.1016/j.tetlet.2016.12.067]
[http://dx.doi.org/10.1016/j.tetlet.2016.01.040]
[http://dx.doi.org/10.1055/s-0036-1589541]
[http://dx.doi.org/10.1016/j.tetlet.2008.01.059]
[http://dx.doi.org/10.1016/j.tet.2008.05.063]
[http://dx.doi.org/10.1002/jhet.3278]
[http://dx.doi.org/10.5155/eurjchem.3.4.455-460.683]
[http://dx.doi.org/10.1016/j.tetlet.2014.08.102]
[http://dx.doi.org/10.1016/j.tetlet.2015.04.068]
[http://dx.doi.org/10.1016/j.tetlet.2014.09.135]
[http://dx.doi.org/10.1055/s-0033-1339490 ]
(b) Grošelj, U.; Podlogar, A.; Novak, A.; Dahmann, G.; Golobič, A.; Stanovnik, B.; Svete, J. Synthesis of tetrahydropyrazolo[1,5-c]pyrimidine-2,7(1H, 3H)-diones. Synthesis, 2013, 45, 639-650.
[http://dx.doi.org/10.1055/s-0032-1318107]
[http://dx.doi.org/10.1002/jhet.2590]
[http://dx.doi.org/10.1055/s-0036-1589136]
[http://dx.doi.org/10.1002/jhet.2816]
[http://dx.doi.org/10.1016/j.tet.2013.10.015]
[http://dx.doi.org/10.1016/j.tetlet.2016.10.058]